咨询热线:

020-3107 8154

Epoxomicin 环氧酶素

Epoxomicin (BU-4061T, Aids010837) 是一种选择性蛋白酶体抑制剂,具有抗炎活性,首要抑制20S蛋白酶体的CH-L活性,也抑制T-L和PGPH催化活性。Epoxomicin 可促进凋亡。Epoxomicin (BU-4061T) 可用于诱导帕金森病动物模型。

  • 货号:
    TK0161
  • 规格:
    1mg
    5mg
    10mg
  • 价格:
    0.00

产品参数

CAS No.134381-21-8
生物活性Epoxomicin (BU-4061T) is an epoxyketone-containing natural product and a potent, selective and irreversible proteasome inhibitor. Epoxomicin covalently binds to the LMP7, X, MECL1, and Z catalytic subunits of the proteasome and potently inhibits primarily the chymotrypsin-like activity. Epoxomicin can cross the blood-brain barrier. Epoxomicin has strongly antitumor and anti-inflammatory activity.
分子式C28H50N4O7
分子量554.72
运输条件Room temperature in continental US; may vary elsewhere.
储存条件Powder, -20°C ,3 years
溶解性数据DMSO : 100 mg/mL (180.27 mM; Need ultrasonic)
体内研究Epoxomicin (0.063-1 mg/kg; intraperitoneal injection; once daily; for 9 days; male BDFX mice) treatment shows significant antitumor effect with the minimumeffective dose of 0.13mg/kg/day.Epoxomicin also effectively inhibits NF-κB activation in vitro and potently blocks in vivo inflammation in the murine ear edema assay.Epoxomicin is injected into adult rats over a period of 2 weeks. After a latency of 1 to 2 weeks, animals developed progressive Parkinsonism with bradykinesia, rigidity, tremor, and an abnormal posture. Postmortem analyses shows striatal dopamine depletion and dopaminergic cell death with apoptosis in the substantia nigra pars compacta.
体外研究Epoxomicin shows quite potent cytotoxicities against all of the cells tested. Epoxomicin inhibits the cells growth of B16-F10, HCT116, Moser, P388 and K562 cells of IC50 values of 0.002 μg/mL, 0.005 μg/mL, 0.044 μg/mL, 0.002 μg/mL and 0.037 μg/mL.Epoxomicin has antiproliferative activity with an IC50 of 4 nM in EL4 lymphoma cells.
纯度及产品资料98%